The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association between tumor biology and occult lymph node metastases before and after primary neoadjuvant therapy (NAT) for patients with early breast cancer.
 
Hans-Christian Kolberg
Stock and Other Ownership Interests - Phaon Scientific; Theraclion
Honoraria - Amgen; AstraZeneca; Carl Zeiss Meditec; Genomic Health; Novartis; Pfizer; Roche; SurgVision; Theraclion
Consulting or Advisory Role - SurgVision
Travel, Accommodations, Expenses - Amgen; Carl Zeiss Meditec; Daiichi Sankyo; Genomic Health; LIV Pharma; Novartis; Pfizer; Roche; Tesaro
 
Cornelia Kolberg-Liedtke
Honoraria - Amgen; AstraZeneca; Celgene; Eisai; Gedeon Richter; Genomic Health; GlaxoSmithKline; Lilly; Novartis; Pfizer; Pierre Fabre; Puma Biotechnology; Roche; Teva
Consulting or Advisory Role - Celgene; Genomic Health; Novartis; Pfizer; Pierre Fabre; Roche; Teva
Research Funding - Boehringer Ingelheim; Eisai; Novartis; Roche
Travel, Accommodations, Expenses - Celgene; Daiichi Sankyo; PharmaMar; Roche; Teva
 
Maja Krajewska
No Relationships to Disclose
 
Ingo Bauerfeind
No Relationships to Disclose
 
Tanja N. Fehm
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; Daiichi Sankyo; Novartis; Pfizer; Roche
Research Funding - Novartis
 
Barbara Fleige
No Relationships to Disclose
 
Gisela Helms
No Relationships to Disclose
 
Annette Lebeau
No Relationships to Disclose
 
Annette Staebler
No Relationships to Disclose
 
Sibylle Loibl
Consulting or Advisory Role - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst); Teva (Inst); Vifor Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Patent Pending EP14153692.0 (Inst)
 
Michael Untch
No Relationships to Disclose
 
Thorsten Kuehn
No Relationships to Disclose